Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Hayata

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
IJU Case Reports|March 15, 2021
Successful surgical resection and reconstruction of scrotal elephantiasisYuto Hattori, Naoki Hayata, Kenji Nakamura, et al.
Asian Journal of Endoscopic Surgery|July 7, 2025
Application of Near-Infrared Fluorescence Imaging Navigation With Indocyanine Green and Near-Infrared Ray Catheter During Robotic Ureteral ReconstructionToru Kanno, Taito Sato, Takeyuki Watanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 3, 2020
[A Case of Primary Mediastinal Seminoma Showing Local Increase in Residual Tumor after Chemotherapy]Yuto Hattori, Kenji Mitsumori, Naoki Hayata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[A Case of Metastatic Renal Cell Carcinoma with LONG-Term Cancer Control by Repeated Dose Adjustment of IFNα]Takeyuki Watanabe, Hiroshi Okuno, Naoki Hayata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 5, 2019
[A Case of Metastatic Clear Cell Renal Cell Carcinoma Showing Long-Term Complete Response after the Discontinuation of Tyrosine Kinase Inhibitor]Naoki Hayata, Toru Yoshida, Yusuke Hama, et al.
Journal of Clinical Medicine|April 28, 2023
Effectiveness and Safety of a Mixture of Nobiletin and Tangeretin in Nocturia Patients: A Randomized, Placebo-Controlled, Double-Blind, Crossover StudyHaruki Ito, Hiromitsu Negoro, Jin Kono, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 30, 2026
[A Case of Asymptomatic Paraganglioma of the Bladder]Taito Sato, Naoki Hayata, Takuya Hida, et al.
Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
Japanese Journal of Clinical Oncology|January 9, 2026
Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative studyKimihiko Masui, Naoki Hayata, Toshinari Yamasaki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
IJU Case Reports|March 15, 2021
Successful surgical resection and reconstruction of scrotal elephantiasisYuto Hattori, Naoki Hayata, Kenji Nakamura, et al.
Asian Journal of Endoscopic Surgery|July 7, 2025
Application of Near-Infrared Fluorescence Imaging Navigation With Indocyanine Green and Near-Infrared Ray Catheter During Robotic Ureteral ReconstructionToru Kanno, Taito Sato, Takeyuki Watanabe, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 3, 2020
[A Case of Primary Mediastinal Seminoma Showing Local Increase in Residual Tumor after Chemotherapy]Yuto Hattori, Kenji Mitsumori, Naoki Hayata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|August 4, 2025
[A Case of Metastatic Renal Cell Carcinoma with LONG-Term Cancer Control by Repeated Dose Adjustment of IFNα]Takeyuki Watanabe, Hiroshi Okuno, Naoki Hayata, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 5, 2019
[A Case of Metastatic Clear Cell Renal Cell Carcinoma Showing Long-Term Complete Response after the Discontinuation of Tyrosine Kinase Inhibitor]Naoki Hayata, Toru Yoshida, Yusuke Hama, et al.
Journal of Clinical Medicine|April 28, 2023
Effectiveness and Safety of a Mixture of Nobiletin and Tangeretin in Nocturia Patients: A Randomized, Placebo-Controlled, Double-Blind, Crossover StudyHaruki Ito, Hiromitsu Negoro, Jin Kono, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 30, 2026
[A Case of Asymptomatic Paraganglioma of the Bladder]Taito Sato, Naoki Hayata, Takuya Hida, et al.
Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
Japanese Journal of Clinical Oncology|January 9, 2026
Pretreatment predictive factors for primary resistance to nivolumab plus ipilimumab in advanced renal cell carcinoma: a multicenter collaborative studyKimihiko Masui, Naoki Hayata, Toshinari Yamasaki, et al.
Pageof 1